Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden
· Delayed Price · Currency is SEK 1.035
-0.045 (-4.17%)
Mar 9, 2026, 5:15 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 31.46 million as of March 9, 2026. Its market cap has decreased by -61.85% in one year.
Market Cap
31.46M
Enterprise Value
23.54M
Revenue
36.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.04
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 31.46M, a decrease of -87.21%. That is a compound annual growth rate of -39.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 32.83M | -6.09% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gabather AB | 21.83M |
| Enorama Pharma AB | 50.27M |
| Vivesto AB | 91.67M |
| Klaria Pharma Holding AB (publ.) | 196.78M |
| Moberg Pharma AB | 487.40M |
| Enzymatica AB | 495.18M |
| Dicot Pharma AB | 608.83M |
| Nanexa AB | 649.29M |